Book Navigation

We are sorry, but signing in with LinkedIn is not possible at this time.


Richard M. Rosenfeld, MD, MPH

Member of the G-I-N Board of Trustees from 2011/2012 to 2013/2014; Chair of the Scientific Committee 2011

Richard M. Rosenfeld is Professor and Chairman of Otolaryngology at SUNY Downstate Medical Center and Long Island College Hospital in Brooklyn, New York. He is Chairperson of the Guideline Development Task Force for the American Academy of Otolaryngology – Head and Neck Surgery (AAO-HNS), and also serves as Editor in Chief of the official Academy journal, Otolaryngology – Head and Neck Surgery.

Dr. Rosenfeld has 20 years of experience with systematic reviews and guideline development, including work with the American Medical Association, American Academy of Pediatrics, AAO-HNS, Agency for Healthcare Research and Quality, ENT Cochrane Center, and the New York State Department of Health.

He is author, coauthor, or editor of 5 books and over 200 scientific publications and textbook chapters. Dr. Rosenfeld has given over 500 scientific presentations and is recognised as an international authority on otitis media and evidence-based medicine. He has been listed for 10 years as one of "America’s Best Doctors" by Castle Connolly.

Vision for G-I-N over the next 5 years

My five-year vision for G-I-N is simple: promote the relevance, importance, and sustainability of G-I-N by working to make G-I-N to Guidelines what Cochrane is to Systematic Reviews: a symbol of quality, excellence, and best practice. G-I-N has grown up quickly in its first decade achieving an international reputation as “the place” for all things guideline-related. Overall membership, however, has remained modest, and many regions of the world are either uninvolved in G-I-N or, in some cases, unaware of its existence or resources.

There are three initiatives I would propose for growing and strengthening G-I-N. First, I would seek to expand, refine, and encourage new regional G-I-N communities, using G-I-N North America as an example. When done properly, in a manner that creates synergy, not competition, regional communities are the best venue for growing the network. Second, I would explore G-I-N endorsed standards for trustworthy clinical practice guidelines, building upon foundations laid by the newly released standards from the Institute of Medicine. This could lead to accreditation of guideline developers, or certification of individual guidelines, as "G-I-N Accredited" or "G-I-N Certified", to indicate a level of excellence. Third, I would work to ensure all aspects of G-I-N are responsive and reflective of member needs, including the library, working groups, communities, conferences, website, and newsletter.


  • GIN North America (NA)

    GIN North America (GIN/NA) is a regional community of clinical practice guideline developers, users and other stakeholders from Canada, Mexico and the United States of America who are interested in improving the effectiveness, rigor and efficiency of guideline development, adaptation, dissemination, implementation and performance measurement. Through a series of educational webinars, regional training conferences, social media and special events, GIN/NA facilitates discussion, partnerships, collaboration and ongoing information sharing within the North American guideline community. The current Chair of the GIN North America Regional Community is Yerado Abrahamian:


    The main objective of GIN PUBLIC is to support effective patient and public involvement in the development and implementation of clinical practice guidelines (CPG's). GIN PUBLIC offers a forum for exchange between patient and public organisations, CPG developers, and researchers. The current Chair of the GIN PUBLIC Working Group is Jane Cowl:

Page last updated: Feb 13, 2020
Back to top